143 related articles for article (PubMed ID: 1853881)
1. Instructions provided by manufacturers for proper use of nonprescription ophthalmic drops.
Lisi DM; Fazio A
Am J Hosp Pharm; 1991 May; 48(5):987-8. PubMed ID: 1853881
[No Abstract] [Full Text] [Related]
2. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
Willig SH
Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
[No Abstract] [Full Text] [Related]
3. OTC labeling reform.
J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
[No Abstract] [Full Text] [Related]
4. The dangers of self-dosing.
Schultz S
US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
[No Abstract] [Full Text] [Related]
5. The patient package insert and its legal implications.
Cook D
Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
[No Abstract] [Full Text] [Related]
6. Labeling information on nonprescription drug products.
Am Pharm; 1988 Nov; NS28(11):24-5. PubMed ID: 3207092
[No Abstract] [Full Text] [Related]
7. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
[TBL] [Abstract][Full Text] [Related]
8. Dosing botanical medicines.
Yarnell E
J Herb Pharmacother; 2005; 5(1):73-8. PubMed ID: 16093237
[No Abstract] [Full Text] [Related]
9. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
[No Abstract] [Full Text] [Related]
10. Secondary pharmaceuticals manufacturing.
Burling JN; Shah PV
Occup Med; 1997; 12(1):29-48. PubMed ID: 9153051
[TBL] [Abstract][Full Text] [Related]
11. Whose liability is it? The pharmacist on trial.
Am Pharm; 1994; NS34 Suppl 1():1-16; quiz 17-9. PubMed ID: 7726096
[No Abstract] [Full Text] [Related]
12. Proposed mandate for instructions and labeling regarding the use of eye drops.
Flach AJ
Arch Ophthalmol; 2009 Sep; 127(9):1207-9. PubMed ID: 19752433
[No Abstract] [Full Text] [Related]
13. FDA's Rx for better medication information.
Farley D
FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
[TBL] [Abstract][Full Text] [Related]
14. Drug safety labeling for doctors.
Hecht A
FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
[TBL] [Abstract][Full Text] [Related]
15. Cisapride and patient information leaflets.
Sukkari SR; Sasich LD
CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
[No Abstract] [Full Text] [Related]
16. New drug label spells it out simply.
Nordenberg T
FDA Consum; 1999; 33(4):29-32. PubMed ID: 10443179
[No Abstract] [Full Text] [Related]
17. Label development and the label comprehension study for over-the-counter drugs.
Brass EP; Weintraub M
Clin Pharmacol Ther; 2003 Nov; 74(5):406-12. PubMed ID: 14586381
[No Abstract] [Full Text] [Related]
18. Developing compliance instructions for drug labeling.
Levy G; Zamacona MK; Jusko WJ
Clin Pharmacol Ther; 2000 Dec; 68(6):586-91. PubMed ID: 11180017
[No Abstract] [Full Text] [Related]
19. Safe & sound. Interview by Helena Gail Rubinstein.
Woodcock J
AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
[No Abstract] [Full Text] [Related]
20. [Patient-oriented package inserts for drugs. Historical overview and current status].
Van Haecht CH; Vander Stichele R; Bogaert M
Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
